** Shares of medical software firm Omnicell OMCL.O fall as much as 16.7% to a near 10-month low of $25.39
** OMCL cuts its 2025 adj profit forecast to a range of $1 and $1.65 per share, compared with previously projected range of $1.65 to $1.85e
** Company, however, maintains its 2025 revenue forecast in the range of $1.11 billion to $1.16 billion
** Company posts Q1 revenue of $270 million vs analysts' estimates of $260 million - data compiled by LSEG
** Up to last close, stock had fallen 44.2% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。